about
Secretion properties, clearance, and therapy in airway diseaseCystic Fibrosis: Lessons from the Sweat GlandLipopolysaccharide hyperpolarizes guinea pig airway epithelium by increasing the activities of the epithelial Na+ channel and the Na+ - K+ pumpSPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavageEffects of intravenous furosemide on mucociliary transport and rheological properties of patients under mechanical ventilationRisk of high blood pressure in salt workers working near salt milling plants: a cross-sectional and interventional studyCystic fibrosis transmembrane conductance regulator dysfunction and its treatmentAirway hydration and COPDLung fluid transport in aquaporin-1 and aquaporin-4 knockout miceInvestigating CFTR and KCa3.1 Protein/Protein InteractionsProline-rich motifs of the Na+/H+ exchanger 2 isoform. Binding of Src homology domain 3 and role in apical targeting in epithelia.Smoking is associated with shortened airway ciliaMolecular insights into the physiology of the 'thin film' of airway surface liquid.Effects of secretagogues on net and unidirectional liquid fluxes across porcine bronchial airways.CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivoBasolateral potassium channels and epithelial ion transport.Regulation of airway tight junctions by proinflammatory cytokines.Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infectionsDesiccation and hypertonicity of the airway surface fluid and thermally induced asthma.High microvascular endothelial water permeability in mouse lung measured by a pleural surface fluorescence method.Cystic fibrosis in adults. From researcher to practitioner.Mild dehydration: a risk factor of broncho-pulmonary disorders?Pathogenesis of cystic fibrosis airways diseaseLipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.Mucus clearance as a primary innate defense mechanism for mammalian airways.Mucociliary clearance in cystic fibrosis.Towards the pharmacogenomics of cystic fibrosis.The application of in vitro methods to safety pharmacology.Infection by Toxoplasma gondii, a severe parasite in neonates and AIDS patients, causes impaired anion secretion in airway epithelia.Silver/silver chloride electrodes for measurement of potential difference in human bronchi.Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitroNoninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH.UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor.Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo.Regulation of murine airway surface liquid volume by CFTR and Ca2+-activated Cl- conductancesAirway surface liquid osmolality measured using fluorophore-encapsulated liposomes.Status of fluid and electrolyte absorption in cystic fibrosis.
P2860
Q21195704-79768D5C-7A84-4E71-967E-1380A0AD7579Q22306467-3E49BC9D-59EA-4B11-931C-51ED87A9E9B4Q23918410-B61B196F-C2F6-42D9-88CA-C8FFF0E7A0B6Q24650650-914C2456-1A26-4DD9-9D9B-FDA4BF354F67Q24803749-A5F2C793-C53D-41DA-899F-0F20B6A4B6A9Q24815676-D8BC77F1-1CD7-49D4-8E45-1F3A2CC90DE5Q26851242-C34D258B-86F8-46A4-BEEE-3C3D6AC42343Q28082617-E04B1D35-A393-41AA-81A3-8591D09622A6Q28593783-72A65075-C5BE-4046-97D3-DA6EBDA8CEC9Q29147472-7AA73CE5-F775-47BB-9413-616C4DB50950Q30175804-8E184E84-C451-43EF-8BB1-A17D5078E48AQ33519042-DC9DD8C3-387F-487E-AFEB-C4385B0B30B9Q33592224-BA345875-1D3E-4A7D-A992-8AFCF8228B90Q33655912-D44418BC-09A5-4F74-AE2A-85D85DA784FFQ34016471-7DD06D6B-3F80-417A-B367-E5D4DB37EC5DQ34022124-2EE2CB58-EE32-4B3A-B601-1ED78273D374Q34061031-1FE888F9-3AA2-4F51-A446-2E80E0155936Q34074636-81A0C765-18B1-43F5-8257-D86BC8DD6F91Q34155449-DC7EAC64-9F82-4144-ACF9-19676EA3FBD3Q34167665-3CB71825-A9E7-4389-8A2A-0A3D7AA3E48DQ34183284-D2457DE0-829A-40D3-8231-27CA7F5550F8Q34284656-2EAFD275-596C-4788-A75F-1810BEFE02F3Q34286627-4E268DCA-43B0-41C3-B2D0-B1426D1DBB5BQ34291214-7E4642A4-B258-44CE-8F5F-E36E60D8A3A6Q34551378-94827AE8-D554-4863-9155-310850A1376CQ34581003-C63AA7CB-BF13-4F65-B500-70FC0C870F4EQ34609152-66CDCFD1-0E1D-45B5-937E-30900D8AC74BQ34775509-9965792C-344C-4CE4-8CEB-E6BF758AD406Q35378566-E8D8D5B5-6E18-42AB-91D9-326EE6FCD8AEQ35532103-103C46F1-AFEC-4E04-BF0C-ADBFAA789A34Q35535921-5E3A1A1C-B4F4-4D6D-91C9-BAB48A112519Q35536342-5C85544E-B0A5-4F8E-9AE0-691BE135396DQ35753331-91E97D35-B373-49C3-9735-C902EA1312E0Q36010684-EEF700EA-A063-45C6-AC4A-580FBA7169FAQ36051563-E9F82C64-C6DF-453F-903A-69E63C120C43Q36295665-F34FEA21-9D16-4353-A127-21B17A5F4222Q36401092-8C5A59A3-C49B-4B7A-AA11-C2177471180AQ36436450-F6FB8902-D61B-49D1-9B3E-0BD7A9E958C6Q36444640-21572212-5179-4C49-8853-13FDBDA5E805Q36488263-BED34FB5-272B-4DA9-9318-B57822796B85
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Human airway ion transport. Part one.
@en
type
label
Human airway ion transport. Part one.
@en
prefLabel
Human airway ion transport. Part one.
@en
P1476
Human airway ion transport. Part one.
@en
P2093
Boucher RC
P304
P356
10.1164/AJRCCM.150.1.8025763
P407
P577
1994-07-01T00:00:00Z